Cargando…
P03 Long term denosumab treatment in osteoporosis - a case series
INTRODUCTION: Studies have shown that denosumab reduces fracture risk and increases bone mineral density and is associated with low adverse events over 10 years. We have reviewed 3 patients in our hospital who have been successfully treated with denosumab 20 injections. CASE DESCRIPTION: Clinical de...
Autores principales: | Premathilake, Nimanthi, Nandagudi, Anupama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532108/ http://dx.doi.org/10.1093/rap/rkad070.024 |
Ejemplares similares
-
P02 When should we stop the antiresorptive medications in patients with osteoporosis?
por: Mohareb, Marwa, et al.
Publicado: (2023) -
Long-term consequences of osteoporosis therapy with denosumab
por: Bandeira, Francisco, et al.
Publicado: (2022) -
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012) -
Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017) -
A review of denosumab for the treatment of osteoporosis
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2014)